|
PUT
|
$7.04 Million
|
66.1K
|
Q2 2025
Added 6.1%
|
|
Bank Of Nt Butterfield&Son L
|
CALL
|
$4,000
|
100
|
Q2 2025
New holding
|
|
Bank Of Nt Butterfield&Son L
|
PUT
|
$4,000
|
100
|
Q2 2025
New holding
|
|
|
CALL
|
$19,000
|
800
|
Q2 2025
New holding
|
|
|
PUT
|
$2,000
|
100
|
Q2 2025
Reduced 87.5%
|
|
|
CALL
|
$3.04 Million
|
22.6K
|
Q2 2025
Reduced 64.63%
|
|
|
PUT
|
$3.36 Million
|
25K
|
Q2 2025
Reduced 66.97%
|
|
|
CALL
|
$267,000
|
9.2K
|
Q2 2025
Added 384.21%
|
|
|
PUT
|
$14,000
|
500
|
Q2 2025
Reduced 98.64%
|
|
Intellia Therapeutics Inc
|
CALL
|
$1.21 Million
|
129K
|
Q2 2025
Added 33.26%
|
|
Intellia Therapeutics Inc
|
PUT
|
$1.16 Million
|
124K
|
Q2 2025
Reduced 24.08%
|
|
|
PUT
|
$3.8 Million
|
49.7K
|
Q2 2025
Reduced 39.83%
|
|
|
CALL
|
$7.55 Million
|
130K
|
Q2 2025
Added 12.78%
|
|
|
PUT
|
$6.47 Million
|
111K
|
Q2 2025
Added 13.14%
|
|
|
CALL
|
$1.28 Million
|
7.6K
|
Q2 2025
Reduced 68.85%
|
|
|
PUT
|
$743,000
|
4.4K
|
Q2 2025
Reduced 91.57%
|
|
|
PUT
|
$1.22 Million
|
9.6K
|
Q2 2025
Reduced 64.84%
|
|
|
CALL
|
$84,000
|
5K
|
Q2 2025
New holding
|
|
|
PUT
|
$6,000
|
400
|
Q2 2025
Added 100.0%
|
|
|
PUT
|
$10,000
|
200
|
Q2 2025
New holding
|
|
|
CALL
|
$2,000
|
300
|
Q2 2025
Reduced 78.57%
|
|
|
PUT
|
$173,000
|
21.7K
|
Q2 2025
Added 2311.11%
|
|
|
CALL
|
$43,000
|
22.4K
|
Q2 2025
Added 1300.0%
|
|
|
PUT
|
$0
|
100
|
Q2 2025
Reduced 95.0%
|
|
|
CALL
|
$99,000
|
1.3K
|
Q2 2025
Reduced 88.39%
|
|
|
PUT
|
$114,000
|
1.5K
|
Q2 2025
Reduced 6.25%
|
|
|
CALL
|
$3.95 Million
|
627K
|
Q2 2025
Added 84.33%
|
|
|
PUT
|
$3.95 Million
|
626K
|
Q2 2025
Added 96.21%
|
|
|
CALL
|
$1.43 Million
|
80.3K
|
Q2 2025
Added 37.5%
|
|
|
PUT
|
$436,000
|
24.5K
|
Q2 2025
Added 198.78%
|
|
|
CALL
|
$58,000
|
7.8K
|
Q2 2025
Added 136.36%
|
|
|
PUT
|
$113,000
|
15.2K
|
Q2 2025
Added 280.0%
|
|
Investment Managers Ser Tr I
|
CALL
|
$1.62 Million
|
86.7K
|
Q2 2025
Added 169.25%
|
|
Investment Managers Ser Tr I
|
PUT
|
$872,000
|
49.5K
|
Q2 2025
Reduced 36.05%
|
|
|
CALL
|
$1,000
|
500
|
Q2 2025
New holding
|
|
|
PUT
|
$1,000
|
1.6K
|
Q2 2025
Reduced 65.22%
|
|
|
CALL
|
$1,000
|
100
|
Q2 2025
Reduced 93.33%
|
|
|
PUT
|
$7,000
|
500
|
Q2 2025
Reduced 89.58%
|
|
|
CALL
|
$440,000
|
1.6K
|
Q2 2025
Reduced 85.96%
|
|
|
PUT
|
$3.14 Million
|
11.4K
|
Q2 2025
Reduced 46.48%
|
|
Envveno Medical Corporation
|
CALL
|
$84,000
|
21.1K
|
Q2 2025
Reduced 28.96%
|
|
Envveno Medical Corporation
|
PUT
|
$8,000
|
2.1K
|
Q2 2025
Reduced 87.43%
|
|
|
CALL
|
$876,000
|
101K
|
Q2 2025
Added 11122.22%
|
|
|
PUT
|
$330,000
|
38.1K
|
Q2 2025
Reduced 54.75%
|
|
|
CALL
|
$8.58 Million
|
70.9K
|
Q2 2025
Reduced 6.59%
|
|
Envista Holdings Corporation
|
CALL
|
$95,000
|
4.9K
|
Q2 2025
Reduced 9.26%
|
|
Envista Holdings Corporation
|
PUT
|
$39,000
|
2K
|
Q2 2025
Added 25.0%
|
|
|
CALL
|
$2.09 Million
|
28.5K
|
Q2 2025
Reduced 22.34%
|
|
|
PUT
|
$227,000
|
3.1K
|
Q2 2025
Reduced 81.55%
|
|
Navitas Semiconductor Corp
|
CALL
|
$6.41 Million
|
978K
|
Q2 2025
Added 303.46%
|
|